C lustered r egularly i nterspersed s hort p alindromic r epeats (CRISPR) interference (CRISPRi) is a powerful technology for sequence-specifi cally repressing gene expression in bacterial cells. CRISPRi requires only a single protein and a custom-designed guide RNA for specifi c gene targeting. In Escherichia coli , CRISPRi repression effi ciency is high (~300-fold), and there are no observable off-target effects. The method can be scaled up as a general strategy for the repression of many genes simultaneously using multiple designed guide RNAs. Here we provide a protocol for effi cient guide RNA design, cloning, and assay of the CRISPRi system in E. coli . In principle, this protocol can be used to construct CRISPRi systems for gene repression in other species of bacteria.
Introduction
About 40 % of bacteria and 90 % of archaea possess an endogenous c lustered r egularly i nterspersed s hort p alindromic r epeats (CRISPR) system for defense against foreign DNA elements, such as viruses, bacteriophages, and plasmids [ 1 , 2 ] . CRISPR utilizes CRISPR-associated (Cas) proteins and noncoding CRISPR (cr) RNA elements to confer genetic immunity [ 1 -4 ] . In type II CRISPR systems, a single endonuclease protein Cas9, in complex with the mature form of crRNA-transacting (tracr) RNA complex, binds specifi cally to the DNA target by sequence complementarity and induces a double-stranded break. Jinek et al. have shown that a designed chimeric single-guide (sg) RNA derived from Streptococcus pyogenes could solely direct the DNA targeting and cleavage activities of Cas9 [ 5 ] . Thus the system allows easy programming of DNA target specifi city, offering a modular, effi cient, and multiplexable tool for genome editing [ 6 -8 ] . In addition to using CRISPR for gene editing, we recently developed a new technology, CRISPR interference (CRISPRi) [ 9 ] , that repurposes the CRISPR system for use in transcription regulation. In CRISPRi, a catalytically dead variant of Cas9 (dCas9) without endonucleolytic activity is coupled with designed small guide RNAs (sgRNAs) complementary to a desired DNA target. The dCas9-sgRNA complex acts to sterically hinder transcription of the targeted DNA, causing gene repression. Because repression by CRISPRi depends on base pairing between a short segment of the sgRNA and the DNA target, new DNA targets can be specifi ed simply by altering the sgRNA sequence. Furthermore, repression by CRISPR is titratable and reversible through use of inducible promoters for both Cas9 and sgRNA expression. The current sgRNA design is a 102-nt chimeric noncoding RNA consisting of a 20-nt base pairing region, followed by a 42-nt Cas9-binding "handle," and a 40-nt transcription terminator (Fig. 1a ) . The 20-nt base pairing region can be freely modifi ed, allowing broad fl exibility in targeting genes for repression. Here, we provide guidance on sgRNA design and plasmid construction for repression of specifi c genes of interest [ 10 , 11 ] . We also provide a protocol for the modular assembly of multiple sgRNA expression cassettes into a single vector using Golden Gate Cloning [ 12 ] . Finally, we provide methods for quantifying CRISPRi repression.
Materials
1. The genome sequence of the target bacterial strain (e.g., a FASTA reference genome).
2. The 102-nt sgRNA reference sequence (see below).
3. (Optional) An RNA secondary structure prediction algorithm such as the Vienna software suite for RNA folding analysis.
• E. coli sgRNA expression plasmid with ampicillin resistance (Addgene ID no. 44251). The sgRNA is expressed from a strong constitutive promoter J23119 ( http://parts.igem.org/ Part:BBa_J23119 ).
• Designed forward sgRNA primers (e.g., 5′-N 20 GTTTTAGA GCTAGAAATAGCAAGTTAAAATAAGGC-3′ for Addgene ID no. 44251, N 20 is the sgRNA base pairing region).
• Universal reverse primer (e.g., 5′-ACTAGT ATTATACCTAGGACTGAGCTAGC-3′ for Addgene ID no. 44251).
• 10 mM ATP (NEB).
• T4 Polynucleotide Kinase Kit (NEB).
• 2× Phusion PCR Master Mix (NEB).
• QiaQuick PCR Purifi cation Kit (Qiagen).
• DpnI Kit (NEB).
• QiaQuick Gel Extraction Kit (Qiagen).
• Quick Ligase Kit (NEB).
• One Shot TOP10 chemically competent E. coli cells (Life Technologies).
• LB plates with 100 µg/mL ampicillin.
• Ampicillin (Sigma).
• TYGPN broth (can be purchased from Amresco) ( see Note 1 ).
• Breatheable Sealing Films (e.g., AeraSeal Breatheable Sealing Films; Excel Scientifi c).
• QiaPrep 96 Turbo Miniprep Kit (Qiagen).
• QiaVac 96 vacuum manifold (Qiagen).
Materials for sgRNA Design

Materials for Single-sgRNA Cloning
• T4 DNA Ligase Kit, 400,000 units/mL (NEB).
• BsaI (NEB).
• 2× Taq Master Mix (NEB).
• E. coli test strain (e.g., K12-strain MG1655).
• E. coli dCas9 expression plasmid with chloramphenicol resistance (Addgene ID no. 44249). The dcas9 gene is under the control of an anhydrotetracycline-inducible promoter P L TetO-1.
• LB plates with 100 µg/mL ampicillin and 20 µg/mL chloramphenicol.
• Chloramphenicol (Sigma).
• Anhydrotetracycline (Clontech).
• RNeasy RNA Purifi cation Kit (Qiagen).
• DNA-free Kit (Ambion).
• Superscript III First Strand Synthesis System (Life Technologies).
• Random Hexamers (Life Technologies).
• qPCR primers.
• Brilliant II SYBR Green Master Mix (Agilent).
Methods
The CRISPRi system requires two components, the dCas9 protein and a sequence-specifi c sgRNA. The key to successful gene repression is to custom design an appropriate sgRNA for the gene target of interest. The main body of the sgRNA, the Cas9 handle and transcriptional terminator, remains constant for different DNA targets. The region that must be designed specifi cally for each DNA target is a 20-nt base pairing region of the sgRNA ( see Note 2 ).
Example: Design an sgRNA target to repress mRFP [ 13 ] expressed in E. coli.
There are four primary constraints to consider in designing the sgRNA base pairing region:
1. Choice of target site: For better repression effi ciency, the base pairing region should bind to the non-template DNA strand of the coding region for the gene to be repressed. Targeting the template DNA strand of the coding sequence is generally ineffective, at most leading to mild repression (~50 %) [ 9 ] . Choosing a target closer to the 5′ end of the gene generally results in greater repression effi ciency.
Cloning MultisgRNA Constructs for Multiplex CRISPRi
Materials for CRISPRi Repression Assays
sgRNA Design
Example: See Fig. 2 for initial sequence of mRFP. PAM adjacency: In addition to the 20-bp base pairing region, the Cas9-sgRNA complex requires a juxtaposed p rotospacer a djacent m otif (PAM) to bind DNA [ 5 , 14 , 15 ] , which is specifi c to the Cas9 being used [ 16 , 17 ] . In the case of S. pyogenes Cas9, the motif is NGG or NAG (N as any nucleotide) [ 6 ] . Thus, the targetable sites are restricted to 20-nt regions 5′ to NGG in the genome (Fig. 1a ) .
Example: To target a particular site on the template DNA strand, search for N 20 -N(G/A)G, and N 20 is the sequence of the base pairing region of sgRNA; to target a site on the nontemplate strand, search for C(C/T)N-N 20 , and the reverse complementary sequence of N 20 is the sequence of the sgRNA base pairing region. For example, to target the non-template DNA strand of the mRFP sequence listed above, one target site is AGACCGCTAACTGAAAGTT (in bold italic) on the non-template strand, with a PAM (CCC, in bold underline). The sgRNA base pairing sequence is thus the reverse complementary, i.e., AACTTTCAGTTTAGCGGTCT.
2. Genomic specifi city: The dCas9-sgRNA complex will bind to any suffi ciently similar DNA sequences that are adjacent to PAM sites. To identify such sequences, run BLAST (blastn; default settings) [ 18 ] searches with each designed sgRNA base pairing region against the complete genome of the organism in which the system will be used. Potential off-target DNAbinding sites with partial complementarity to the sgRNA should be evaluated for degree of homology; nucleotides closer to the PAM have a greater impact on relative binding affi nity. One or two mismatches, particularly in the PAM-adjacent 12-nt portion of the target (the "seed" region), are suffi cient to reduce binding effi ciency by an order of magnitude or more [ 9 ] . 3. Folding quality (optional): Generate the full sgRNA sequence by appending the target DNA sequence (replacing T with U) to the 5′ end of the sgRNA sequence (5′ 20-nt base pairing reg ion + GUUUUAGAGCUAGAAAUAGCAAGUUAAA AUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGG CACCGAGUCGGUGCUUUUUUU -3′). Using a folding algorithm such as the Vienna suite [ 20 ] , compare the predicted structure of the sgRNA containing the new 20-nt base pairing region to the structure of a functionally validated sgRNA. If the dCas9 binding handle is disrupted the sgRNA will bind poorly to dCas9, and repression effi ciency will be reduced.
Primers for the target-specifi c inverse PCR (iPCR; described in [ 21 ] and Fig. 1b ) are paired with a universal reverse primer to generate new sgRNA expression vectors. These vectors are transformed into a cloning strain of E. coli and then grown to a suffi cient quantity for plasmid purifi cation. The forward and reverse primers are homologous to the template vector, with the forward primer containing a 20-nt base pairing region at the 5′ end unique to each sgRNA (Fig. 1b ) . The forward primer anneals to the part of the vector that encodes the dcas9-binding handle, immediately downstream of the 20-nt base pairing region. The following protocol addresses parallel or pooled cloning of many vectors, each of which expresses a single sgRNA ( see Note 3 ).
1. iPCR can be performed using individual primer pairs (i.e., one sgRNA product per reaction) or by pooling sets of forward primers that contain different sgRNA sequences with a universal reverse primer (i.e., numerous sgRNA products per reaction). Pooling can reduce labor and reagent consumption, but may cause bias (e.g., differential amplifi cation of specifi c sgRNA plasmids) or other problems (e.g., mispriming) in the PCR reaction. To form pools, combine multiple forward primers in equal portion so that the total concentration of the primer pool is the concentration listed below. (The concentration of any individual forward primer will be 1/N times the total concentration, where N is the number of primers in the pool. The reverse primer should be used at the same concentration, as listed.) For construction of large sgRNA libraries (>96), we typically start with multiple iterations of a pooled approach followed by individual cloning of sgRNA plasmids to This protocol describes construction of a single vector that contains multiple sgRNAs for targeting two or more genes in E. coli using Golden Gate cloning [ 12 ] , which facilitates ligation of up to ten DNA fragments in one reaction. Golden Gate cloning employs BsaI, a type IIS restriction enzyme that recognizes a sequence 5′ of the actual cut site, allowing creation of arbitrary 4-nt overhangs (Fig. 3a ) . Ligation of non-palindromic 4-nt overhangs allows efficient assembly of sgRNAs in a defi ned order (Fig. 1c ) . We use primers with added BsaI sites and overhangs to amplify sgRNA expression cassettes using PCR (Fig. 3b ) . BsaI recognition sites are removed from the sgRNA insert during digestion and thus are not igem.org/Part:BBa_J23119 ) that drives expression of a single sgRNA. The Golden Gate cloning procedure described below streamlines creation of multi-sgRNA vectors for multiplex CRISPRi (Fig. 1c ) ( see Note 4 ):
1. Design primers to amplify the sgRNA expression fragments with added BsaI sites and custom overhang sequences (Fig. 3c ).
2. PCR amplify fragments using NEB Phusion Polymerase Master Mix, with 0.5 µL of 100 µM primers: 3. Run the PCR products on 1 % agarose gel to verify that the PCR is successful and specifi c (no secondary bands).
4. PCR purifi cation using standard protocol using, e.g., QiaQuick PCR Purifi cation Kit.
5. Quantify the concentration of each purifi ed PCR product using a Nanodrop. If the target gene encodes a fl uorescent protein, transcriptional repression using CRISPRi can be assayed using methods such as fl ow cytometry [ 9 ] . More generally, transcriptional repression of endogenous genes can be assayed using quantitative PCR (qPCR) ( see Note 5 ). 4. Grow overnight at 37 °C at 900 RPM shaking speed in a deepwell plate shaker.
5. Dilute overnight cultures 1:1,000 into 3 mL LB in 18 mL glass culture tubes, supplemented with 1 µM anhydrotetracycline to induce dCas9 expression. Grow cultures for 6 h at 37 °C in a culture tube rotator.
6. When cells reach late-exponential phase, mix 600 µL of culture with 600 µL of −20 °C methanol in a microcentrifuge tube, and then pellet cells at maximum speed (e.g., 18,000 × g ) for 1 min.
7. Pipette off the supernatant and then extract the RNA using Qiagen RNeasy RNA purifi cation kit following the manufacturer's instructions.
8. Following RNA isolation, remove genomic DNA using Ambion DNA-Free kit following the manufacturer's instructions.
9. Arbitrarily choose six DNA-free RNA samples and add 1 µL of 100 mg/mL RNase A. These will be used to ensure that there is no contaminating DNA in the samples when the qPCR is run.
10. Synthesize cDNA using Invitrogen SuperScript III First-Strand Synthesis System with random hexamers following the manufacturer's instructions. Make working stocks by diluting the cDNA 1:10.
11. Using Primer3 software [ 22 ] 
Notes
TYGPN medium:
For 1 L: 750 mL ddH 2 O, 5 g Na 2 HPO 4 , 10 g KNO 3 , 20 g tryptone, 10 g yeast extract, 10.7 mL 75 % glycerol Be sure to dissolve the salts thoroughly fi rst and then mix in the remainder of the reagents. Autoclave for 45 min.
2. The fi nal repression effect of a given sgRNA may depend on multiple factors, including sequence composition of the basepairing region, off-target binding, target location relative to the transcription start site, and possibly even local chromosome architecture [ 9 ] .
3. Protocol 3.2 should be preferentially performed in a single day, or samples should be stored at −20 °C and used soon after to avoid loss of phosphate groups prior to the ligation step.
4. For protocol 3.3, we found that DNA containing eight or more tandem sgRNA cassettes does not effi ciently amplify by PCR. If desired constructs consist of eight or more sgRNA cassettes, it may be necessary to use two compatible plasmids for co-expression of multiple sgRNAs.
5. Repressing the fi rst gene in an operon likely has a similar repressive effect on all downstream genes in the same operon.
